KCTD10 and breast carcinoma: Here, we showed that KCTD10 knockdown increased the viability and clonogenic survival of breast cancer cells by stabilizing SLC7A11 to confer resistance to ferroptosis, which was abrogated by either SLC7A11 knockdown or treatment with a ferroptosis inducer.